Chase AIPricingFAQs
Display currency
Loading news…

Shionogi Pharma Inc.

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Atlanta, Georgia, United States Founded 1992 501-1000 employees For Profit

Sciele Pharma is involved in the marketing and development of prescription products focused on diabetes, women’s health and pediatrics.

Shionogi Pharma Inc. was acquired by Shionogi in 2008 for $1B.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
2
Monthly Visits
Available in Pro
Contacts
0
Patents
2

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Delisted
Ticker
SCRX
Exchange
NASDAQ
IPO date
May 31, 2000
Delisted
Oct 9, 2008

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Patents granted
2
Trademarks
0
Top patent class
a61

Company Info

Founded
1992
Employees
501-1000
Operating status
Closed
Company type
For Profit
Org types
company
HQ
Atlanta, Georgia, United States
Region
Greater Atlanta Area, East Coast, Southern US
Exit date
May 31, 2000
Closed
Sep 1, 2008

Signals & Scores

Heat score
Low
Trend (7d)
-0.1
Trend (30d)
-0.4
Trend (90d)
-0.5

Acquisitions by Shionogi Pharma Inc.

Loading columns…
0 of 0Show
Page 1 / 1

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Shionogi Pharma Inc.

Loading news…

FAQs about Shionogi Pharma Inc.

People who checked this page also checked these

Sectors Shionogi Pharma Inc. invests & acquires in

M&A by year

Browse the full Acquirezy directory.
Shionogi Pharma Inc. - Company Profile, Full Acquisitions List, Funding and Investments